Surgical renal artery reconstruction after percutaneous transluminal angioplasty

Percutaneous transluminal renal angioplasty (PTRA) is a controversial treatment for renal artery stenosis. This article discusses whether or not a prior attempt at PTRA compromises a subsequent elective or emergent surgical revascularization. Thirteen patients had surgical renal artery reconstruction after one or more PTRAs. Eight of the patients were treated because of atherosclerotic renal artery disease whereas five had a form of fibromuscular dysplasia. Five patients had renal artery injury directly related to the angioplasty. Four of these kidneys were saved. Eight patients were treated from 6 to 920 days after PTRA because of recurrent stenosis or occlusion of the renal artery. Only one of these kidneys was lost, an attempt at revascularization of a small kidney that failed to resume function. A prior attempt at PTRA did not compromise the ability of subsequent surgical revascularization to ameliorate hypertension. We conclude that surgical renal revascularization is not made less likely to succeed by a previous attempt at PTRA; even if the renal artery is thrombosed or perforated during the procedure, a reasonable chance of renal salvage is obtained by immediate surgical revascularization.     

Current status of percutaneous transluminal angioplasty

With the development of a dilating balloon catheter that permits percutaneous treatment of many arterial stenoses and some occlusions, a definite advance in the therapy of peripheral vascular disease has been made. It is still too early to be certain what ultimate position this means of therapy will take in the overall treatment of vascular disease, as its use is still being extended and long-term results are not yet clearly known. When compared with surgical therapy, however, it has some striking advantages, although the durability of its effect appears to be less. Despite the fact that more time and experience are needed before its ultimate position is established, we believe that the evidence to date warrants inclusion of this form of therapy in the armamentarium of every major vascular center.     

Surgically relevant complications in percutaneous transluminal angioplasty

Seven significant surgical complications in 118 patients after PTA-treatment of the lower extremities are presented. In two cases the puncture site in the vessel had to be sutured, in three patients we had to perform a femoro-popliteal bypass, once a TEA with profundaplasty and in another case an embolectomy of the trifurcation. Our experience reveals that with the indication for PTA, the rate of significant complications and their surgical consequences has to be considered too. A close cooperation between Radiologist, Angiologist and Surgeon is of importance.     

Morphological changes after percutaneous transluminal angioplasty

BACKGROUND: Percutaneous transluminal angioplasty (PTA) dilates constricted arteries at the circle of Willis to reverse cerebral ischemia caused by cerebral vasospasm. Although 90% of the patients show angiographic improvement after PTA, only 70% show clinical improvement. Why some patients do not improve after PTA is unknown. We report on a 48-year-old woman who failed to improve after PTA and died from aneurysm rerupture. Pathologic studies were performed to determine why PTA failed to reverse the symptoms of cerebral ischemia. METHODS: The arteries of the brain were studied by light microscopy using Gomori's trichrome stain. The arteries were also studied by scanning and transmission electron microscopy. RESULTS: The arteries that were dilated with PTA showed compression of the connective tissue, stretching of the internal elastic lamina, and a combination of compression and stretching of the smooth muscle. The small arteries and arterioles that had been treated with an infusion of intraarterial papaverine were constricted with a thickened intimal layer. CONCLUSION: The persistence of cerebral vasospasm in small and perforating arteries may contribute to the failure of cerebral ischemia to reverse after PTA.     

Septic endarteritis after percutaneous transluminal angioplasty

A case of septic endarteritis leading to septic arthritis and septic emboli occurred after percutaneous transluminal angioplasty. To our knowledge, this is the first reported instance of arterial wall infection potentially caused by percutaneous transluminal angioplasty. Treatment consisted of long-term intravenous antibiotics and drainage of the septic joint.     

Changes in peripheral hemodynamics after percutaneous transluminal angioplasty

We measured ankle/arm pressure indexes and blood flow rates before and after performing percutaneous transluminal angioplasty in 36 extremities. Flow rates through the leg were determined with a magnetic resonance blood flow scanner. All patients had claudication; one had gangrene, another had an ulcer, and two complained of rest pain. The median age was 65 years, and 72% were men. There were 25 dilations of the iliac artery, 12 of the superficial femoral artery, and eight of the popliteal arteries; nine patients had two arterial segments dilated. Nineteen legs had ankle/arm pressure indexes before percutaneous transluminal angioplasty of less than 0.80 (range 0.51 to 0.75); their flow rates averaged 40 +/- 20 (SD) ml/min. After percutaneous transluminal angioplasty flow and pressure increased significantly in 14 of these 19 legs, and three had no hemodynamic improvement; in one leg only pressure and in another only flow increased significantly. The remaining 17 extremities had ankle/arm pressure indexes before percutaneous transluminal angioplasty ranging from 0.81 to 1.09; their flow rates averaged 53 +/- 27 (SD) ml/min. Abnormal flow rates were detected in 15 of these 17 extremities. With near-normal ankle/arm pressure indexes no significant increase in pressure was anticipated. Flow rates augmented to 75 +/- 28 (SD) ml/min after percutaneous transluminal angioplasty; a significant increase in flow was noted in 12 legs (71%). For patients with ankle/arm indexes before percutaneous transluminal angioplasty of less than 0.80, either pressure or flow measurements should corroborate the benefits of the operation, whereas if the ankle arm index is greater than 0.80, flow measurements are most likely to substantiate changes in peripheral hemodynamics.     

Coronary-subclavian steal corrected with percutaneous transluminal angioplasty

We describe a case of coronary-subclavian steal syndrome treated with percutaneous transluminal angioplasty. A 58-year-old female who had her first coronary bypass operation 6 years previously and a second operation 3 years previously involving the left internal mammary artery and right gastroepiploic artery, developed unusual angina on effort characterized by left precordial pain, pain in the left shoulder and arm, tinnitus and dizziness. Angiography revealed retrograde flow to the left subclavian artery via the left vertebral artery and left internal mammary artery. Severe stenosis of the left subclavian artery was demonstrated at its ostium. Restoration of antegrade flow to the vertebral artery and left internal mammary artery by transluminal angioplasty resulted in complete resolution of these symptoms.     

Angioscopy before and after percutaneous transluminal angioplasty

Background: Reports of endoscopic visualization of the vascular lumen date back to the 1970s. While angioscopy is already used as a routine intraoperative technique in a variety of therapeutic procedures, there are only few reports on the use of percutaneous angioscopy in the course of radiologic interventions. Methods: Fifty two angioscopies before and after percutaneous transluminal angioplasty (PTA) were performed in 30 patients. A 1.4 mm angioscope was used together with a roller-pump (n=42) or a pressure infusion set (n=10) for fluid irrigation. Results: Angiographically, 24 stenoses and 6 occlusions of the superficial femoral artery (SFA) were diagnosed. Angioscopically, circular stenoses were visualized in 14 patients, eccentric stenoses in 7 patients. 6 angiographically diagnosed occlusions were identified angioscopically as high-grade stenoses in 3 cases and fresh thromboses in the remaining 3 patients. In 5 patients (17%) the therapeutic management was modified as a result of the angioscopic findings. After PTA angioscopy showed partly dissected plaques and freely floating intimal flaps which were not visualized angiographically. Conclusions: Thus a direct angioscopic view made a more accurate diagnosis possible. Consequently angioscopy may aid in the selection of the appropriate interventional modality and it may serve as an immediate quality control after PTA.      

Complications of percutaneous transluminal angioplasty (PTA)

PTA can be regarded as an enrichment of the treatment alternatives used for chronic arterial vascular disease. Complications requiring corrective vascular surgery arose in 6% of 194 catheter dilatations. They could be observed at the sites of puncture, recanalization and dilatation. The complications associated with PTA do not constitute any burden for emergency surgery. The complication rate is justifiable within the treatment concept.     

Monitoring functional patency of percutaneous transluminal angioplasty.

Duplex scanning and Doppler-derived blood pressure measurements were used to serially monitor lower limb hemodynamics in 73 patients who underwent percutaneous transluminal angioplasty. Ninety percutaneous transluminal angioplasty sites judged technically satisfactory by arteriography were evaluated. Significant hemodynamic improvement was seen in 81 (90%) of the 90 limbs, although both hemodynamic and clinical improvement were achieved in only 77 (86%) limbs. Duplex scanning within 1 week of successful angioplasty identified moderate (20% to 49% diameter reduction) or severe (greater than 50% diameter reduction) residual stenosis in 49 (63%) of 77 balloon-dilated arterial segments. The presence of a greater than 50% diameter reduction residual stenosis predicted further restenosis and late clinical failure (11% success rate at 1 year). When the degree of residual stenosis at the percutaneous transluminal angioplasty site was less than 50% diameter reduction by duplex scanning, the procedure was durable (80% success rate at 2 years), even in patients with critical ischemia, poor runoff, or diabetes mellitus.     

Surgical revascularization following unsuccessful percutaneous transluminal coronary angioplasty

From September, 1980, through August, 1981, 353 patients underwent attempted percutaneous transluminal coronary angioplasty (PTCA). Twenty-seven patients (7.6%) subsequently underwent elective myocardial revascularization without death or complicating PTCA. Surgical support in the first 2 months involved a fully-staffed operating room standing idle. During the last 10 months, patients requiring emergency revascularization were accommodated in the first operating room available. All 17 patients undergoing emergency revascularization had severe chest pain and 12 patients had ST-segment elevation on the electrocardiogram. The average time from onset of ischemia to revascularization was 135 minutes and did not change over the period of study. Improvement in the electrocardiogram and myocardial function were frequently noted with restoration of flow by the vein graft. Two patients (12%) required inotropic drug support following revascularization. All 12 patients with ST-segment elevation preoperatively had elevated myocardial enzyme levels postoperatively, including five patients (29%) with new Q waves on the electrocardiogram. Myocardial necrosis did not correlate with time to revascularization, number of diseased vessels, the artery being instrumented, the mechanism of ischemia, or the presence of collateral flow. There were no deaths. Because of the high incidence of myocardial infarction despite prompt revascularization, we now routinely insert the intra-aortic balloon pump in the catheterization laboratory in patients with refractory myocardial ischemia requiring emergency revascularization. Prompt safe revascularization for acute ischemia following PTCA can be achieved without expensive and inefficient standby of cardiac surgical facilities. Transmural myocardial ischemia following complicated PTCA is frequently associated with evidence of myocardial necrosis despite prompt surgical revascularization. Greater salvage of ischemic myocardium may be possible if the intra-aortic balloon pump is used in the interval between PTCA-induced injury and surgical revascularization.     

Surgical revascularization following failed percutaneous transluminal coronary angioplasty

Percutaneous transluminal coronary angioplasty (PTCA) was performed on 200 patients and failed in 36, 12 of whom underwent myocardial revascularization within 3 hours after the angioplasty attempt. Elective operations were performed without complications in the other 24 cases. The 12 emergency operations were necessitated by major complications during or after PTCA, viz, coronary occlusion (6 patients) coronary dissection (2) and failed catheter passage or dilation with severe myocardial ischemia (4). Three of these 12 patients had signs of acute myocardial infarction preoperatively, and new infarction appeared postoperatively in two cases. All eight patients with ST-segment elevation preoperatively had raised levels of myocardial enzymes postoperatively, and two of them had new Q-waves. Three of the 12 patients required inotropic drugs following revascularization. There was one postoperative death. When complications arise in PTCA, emergency operation should be undertaken. When PTCA fails, but without complications, surgery can be electively performed.     

Complications after percutaneous transluminal angioplasty and vascular surgery

Percutaneous transluminal angioplasty (PTA) is an accepted technique in the treatment of occlusive vascular disease. We report complications associated with balloon catheter dilatation and their treatment in the period from 1. 1. 1986 to 31. 3. 1990. Complications were found at the site of dilatation and the site of insertion of the catheter, mostly in the pelvic and femoral region. Surgical correction was successful in all patients, however three patients died postoperatively of acute myocardial ischemia. To avoid these complications close co-operation between the radiologist performing the dilatation and the vascular surgeon managing the complications should be assured.     

Consequences of immediate failure of percutaneous transluminal angioplasty.

Percutaneous transluminal angioplasty (PTA) is often used for patients who would not previously have been treated, due for example, to their poor general condition or their symptoms being relatively mild. The approximate overall initial success and complication rates are 80% and 10%, respectively. Iliac angioplasties fare rather better than superficial femoral dilatations. There is little information on the outcome of those patients in whom the procedure cannot be completed satisfactorily or who have complications. From 1985 to December 1990, 318 PTAs have been attempted on our unit, the majority within the last 3 years. In 53 (17%) the dilatation was not carried out, due to inability to position the guidewire (31) or balloon (16) satisfactorily, to disease progression (3) or systemic problems (3). None of these patients was made worse and 10 subsequently had a successful angioplasty. Complications occurred in 28 (9%). These included distal embolisation (10), bleeding (9), dissection (1), thrombotic occlusion (4) and vessel rupture (4). Complications were more common after superficial femoral, compared with iliac angioplasty (P < 0.02, chi 2 test). Eight patients with occlusion or embolus were treated with thrombolysis, five successfully. Three of these patients, and seven others, had surgical intervention (three within 6 h of angioplasty). Ten patients were treated conservatively, one died. Of the 28 patients who sustained complications, 27 were improved compared with their status before angioplasty, once their complication had been dealt with. PTA is a generally safe procedure and when complications occur most can be dealt with effectively.     

Long-term hemodynamic evaluation of lower extremity percutaneous transluminal angioplasty

Percutaneous transluminal angioplasty (PTA) has provided an alternative method of treatment for occlusive disease of the lower extremities. However, the long-term durability of PTA compared with that of surgical reconstruction has not been adequately evaluated. This study was undertaken to assess the long-term hemodynamic results of PTA. Thirty-four dilatations performed on 28 patients over a 30-month period and followed for 1 to 53 months were reviewed. Twenty-two dilatations were done in the iliac arteries, seven in the superficial femoral, three in the popliteal, one in the peroneal artery, and one at a bypass graft anastomosis. All patients underwent noninvasive measurements of lower extremity segmental pressure prior to dilatation and at scheduled follow-up intervals. Success was defined as an increase in the Doppler-derived segmental lower extremity/brachial index of greater than or equal to 0.15 or normalization of the index (greater than or equal to 0.90), measured at the closest level distal to the site of dilatation. Sixteen of 22 iliac dilatations (72.7%) were initially successful. However, long-term success was maintained in only six (27.6%). Cumulative hemodynamic success for the initially successful iliac dilatations was 28% at 3 years. Seven of 11 (63.6%) dilatations performed on infrainguinal arteries were initially successful; however, only two (18.2%) experienced continued success. Cumulative hemodynamic success for the initially successful infrainguinal dilatations in this group was 35% at 3 years. Although immediate patency and improvement in hemodynamic parameters are similar to comparable surgical procedures, these results demonstrate that PTA is not as durable as conventional surgical procedures.     

Nonsurgical treatment of renovascular hypertension by percutaneous transluminal angioplasty

A case of renovascular hypertension treated with percutaneous transluminal angioplasty is reported. Our patient was a 22-year-old housewife with 90 per cent stenosis of the right renal artery due to fibromuscular dysplasia. The renal artery was dilatated by percutaneous transluminal angioplasty with a Grützig balloon catheter to 25 per cent stenosis. Five hours after the procedure, blood pressure decreased from 180/114 mmHg to 130/95 mmHg; one day after, plasma renin activity fell from 4.7 ng/ml/hr to 1.7 ng/ml/hr. The patient was rehospitalized six months after percutaneous transluminal angioplasty to examine restenosis of the dilatated renal artery. Although her blood pressure remained normotensive and plasma renin activity was normal, replasty was performed since selective renal arteriography revealed 50 per cent stenosis.